LCP
BIIB icon

LGT Capital Partners’s Biogen BIIB Stock Holding History

LGT Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28,940
Closed -$8.4M – 56
2018
Q2 		$8.4M Buy
28,940
+1,982
+7% +$557K 0.65% 47
2018
Q1 		$7.38M Sell
26,958
-10,932
-29% -$3.39M 0.63% 51
2017
Q4 		$12.1M Buy
37,890
+2,720
+8% +$873K 1.13% 39
2017
Q3 		$11M Sell
35,170
-116,985
-77% -$34.6M 1.11% 40
2017
Q2 		$41.3M Buy
152,155
+34,524
+29% +$9.13M 4.14% 2
2017
Q1 		$32.2M Buy
117,631
+20,600
+21% +$5.82M 3.66% 3
2016
Q4 		$27.5M Buy
97,031
+12,041
+14% +$3.57M 3.74% 1
2016
Q3 		$26.6M Buy
84,990
+760
+0.9% +$225K 3.73% 2
2016
Q2 		$20.4M Buy
84,230
+25,150
+43% +$6.63M 3.53% 3
2016
Q1 		$15.4M Buy
59,080
+9,250
+19% +$2.44M 2.78% 9
2015
Q4 		$15.3M Buy
49,830
+35,330
+244% +$10.2M 3.44% 4
2015
Q3 		$4.23M Buy
+14,500
New +$4.79M 1.24% 34

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LGT Capital Partners's BIIB Position: Q3 2018 in Review

LGT Capital Partners sold out of Biogen (BIIB) in Q3 2018, closing a stake of 28,940 shares — an estimated $8.4M sold.

LGT Capital Partners first reported a position in BIIB in Q3 2015 and held it in 12 quarters. The position peaked at $41.3M in Q2 2017. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • LGT Capital Partners reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • LGT Capital Partners sold 28,940 Biogen shares in Q3 2018, an estimated $8.4M.
  • LGT Capital Partners first reported a position in Biogen in Q3 2015 and held it in 12 quarters.
  • LGT Capital Partners's Biogen position peaked at $41.3M in Q2 2017.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on LGT Capital Partners's 13F filing for Q3 2018, filed 18 Oct 2018.